Optiver Holding
ARCT icon

Optiver Holding’s Arcturus Therapeutics ARCT Stock Holding History

Optiver Holding’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$710 Sell
92
-30
-25% -$219 ﹤0.01% 2113
2025
Q4 		$748 Sell
122
-84
-41% -$907 ﹤0.01% 2244
2025
Q3 		$3.8K Buy
+206
New +$3.31K ﹤0.01% 1996

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Optiver Holding's ARCT Position: Q1 2026 in Review

Optiver Holding reduced its Arcturus Therapeutics (ARCT) stake by 25% in Q1 2026, selling an estimated $219 and leaving 92 shares worth $710. The position accounts for ﹤0.01% of the portfolio, ranked #2113.

Optiver Holding first reported a position in ARCT in Q3 2025 and has held it in 3 quarters since. The position peaked at $3.8K in Q3 2025. 124 funds tracked by Wall St. Rank hold ARCT as of Q1 2026.

  • Optiver Holding held 92 shares of Arcturus Therapeutics worth $710 as of Q1 2026.
  • Optiver Holding sold 30 Arcturus Therapeutics shares in Q1 2026, an estimated $219.
  • Arcturus Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #2113 holding.
  • Optiver Holding first reported a position in Arcturus Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Arcturus Therapeutics position peaked at $3.8K in Q3 2025.
  • 124 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.